1-14 of 14
Dahlia Sano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A real-world analysis of safety and outcomes with first line nivolumab in combination with doxorubicin, vinblastine, and dacarbazine (NAVD) in patients with classic Hodgkin lymphoma (cHL) – a multicenter cohort study

Free
Allison Bock, Efrat Luttwak, Elena Nazarenko, Yizhe Xu, Swetha Thiruvengadam, Dahlia Sano, Kanithra Sekaran, John Vaughn, Daniel Reef, John Sharp, Ajay Major, Vrutti Patel, Nicole Araujo, Ritwick Mynam, Gordon Smilnak, Marisa Palmeri, Anuja Abhyankar, Drew Gerber, Ayo Falade, Praveen Ramakrishnan Geethakumari, Madiha Iqbal, Grace Baek, Mengyang Di, Boyu Hu, Urshila Durani, Hua-Jay Cherng, Alex Niu, Joanna Rhodes, Krithika Shanmugasundaram, Priyanka Pophali, Tatyana Feldman, Jakub Svoboda, Timothy Voorhees, Natalie Grover, Catherine Diefenbach, Reem Karmali, Yasmin Karimi, Alex Herrera, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 1841.
https://doi.org/10.1182/blood-2025-1841
Published: 2025
Journal Articles

Promising response rates and manageable safety with mosunetuzumab plus lenalidomide (Mosun-Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): US extension cohort from the Phase III CELESTIMO study

Free
Dahlia Sano, Nancy Bartlett, Elizabeth Budde, Brett Brinker, Rakhee Vaidya, Sunil Babu, Catherine Diefenbach, Chijioke Nze, Connie Ma, Andrea Knapp, Michelle Doral, Vivian Chen, Paloma Hauser, Michael C. Wei, Pretibha Moorthy, Anna Phillips, Natalie Surh, Adam Jan, Enkhtsetseg Purev, Nina Wagner-Johnston
Journal: Blood
Blood (2025) 146 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2025-1800
Published: 2025
Journal Articles

Nivolumab with doxorubicin, vinblastine, and dacarbazine (NAVD) in older adults with classic Hodgkin lymphoma: Do S1826 results hold up in the real world?

Free
Pallawi Torka, Allison Bock, Elena Nazarenko, Yizhe Xu, John Vaughn, Swetha Thiruvengadam, Ajay Major, Kanithra Sekaran, Daniel Reef, Calvin Lee, Gordon Smilnak, Efrat Luttwak, Vrutti Patel, Harsh Shah, Andrew Ip, Grace Baek, Ritwick Mynam, Dahlia Sano, Drew Gerber, Ayo Falade, Marisa Palmeri, Rudy Mrad, Madiha Iqbal, John Sharp, Timothy Voorhees, Praveen Ramakrishnan Geethakumari, Joanna Rhodes, Urshila Durani, Hua-Jay Cherng, Yasmin Karimi, Priyanka Pophali, Mengyang Di, Tatyana Feldman, Jakub Svoboda, Krithika Shanmugasundaram, Alex Niu, Natalie Grover, Reem Karmali, Alex Herrera, Catherine Diefenbach, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3622.
https://doi.org/10.1182/blood-2025-3622
Published: 2025
Journal Articles

Risk Factors for Severe Infection in Patients Receiving Bispecific Antibody Therapies for Lymphoma

Free
Iman Ahmed, Victoria Nachar, Lydia Benitez, Shannon A. Carty, Dahlia Sano, Ryan A. Wilcox, XI Yang, Jonathan Weiss, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3105.
https://doi.org/10.1182/blood-2024-205406
Published: 2024
Journal Articles

Assessment of Tumor Metabolic Volume (TMV) As a Predictor of Outcomes in Patients with Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma (PMBCL)

Free
Henry Dumke, Kellen Fitzpatrick, Tycel Phillips, Mark S Kaminski, Shannon A. Carty, Ryan A. Wilcox, Dahlia Sano, Malathi Kandarpa, Avery Polk, Benjamin L Viglianti, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 6462.
https://doi.org/10.1182/blood-2024-203822
Published: 2024
Journal Articles

Outcomes of Sequenced Therapy in Mantle Cell Lymphoma in Patients Treated with First-Line Autologous Stem Cell Transplantation and Second-Line BTK Inhibitor

Free
Michael McLane, Victoria Nachar, Shannon A. Carty, Mark S Kaminski, Tycel J. Phillips, Dahlia Sano, Jonathan Weiss, Ryan A. Wilcox, Iman Ahmed, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 6348.
https://doi.org/10.1182/blood-2024-209170
Published: 2024
Journal Articles

Risk Factors for Cytokine Release Syndrome in Patients Receiving Bispecific Antibodies for B-Cell Lymphoma: A Single-Center, Retrospective Cohort Study

Free
XI Yang, Iman Ahmed, Victoria Nachar, Shannon A. Carty, Ryan A. Wilcox, Jonathan Weiss, Dahlia Sano, Tycel J. Phillips, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 4477.
https://doi.org/10.1182/blood-2024-211076
Published: 2024
Journal Articles

Cost Effectiveness of Mosunetuzumab and CAR-T Cell Therapy in Relapsed/Refractory Follicular Lymphoma

Free
Manisha Lin, Jonathan Weiss, Tycel J. Phillips, Dahlia Sano, Shannon A. Carty, Monalisa Ghosh, Iman Ahmed, Victoria Nachar, David Hutton, Yasmin H. Karimi
Journal: Blood
Blood (2023) 142 (Supplement 1): 256.
https://doi.org/10.1182/blood-2023-182244
Published: 2023
Journal Articles

Efficacy and Safety of Retreatment with Brentuximab Vedotin in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or CD30-Expressing Peripheral T Cell Lymphoma

Free
Dahlia Sano, Sairah Ahmed, Jingmin Liu, Scott Knowles, Seung Tae Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 12003–12004.
https://doi.org/10.1182/blood-2022-158225
Published: 2022
Journal Articles

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Free
Krish Patel, Jeffrey A. Zonder, Dahlia Sano, Michael Maris, Alexander Lesokhin, Gottfried von Keudell, Catherine Lai, Rod Ramchandren, Tina Catalano, Gloria H. Y. Lin, Bob Uger, Penka S. Petrova, Naomi Molloy, Ingmar Bruns, Swaminathan P Iyer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3560.
https://doi.org/10.1182/blood-2021-153683
Published: 2021
Journal Articles

Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse

Free
Dahlia Sano, MD, Paolo Strati, MD, Pedro Alcedo, MD, V Ahalya Rao, MD, Prachee Singh, Roberto N. Miranda, MD, Jillian R Gunther, MD PhD, Chelsea Camille Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Feng Lei, MS, Hun Ju Lee, MD, Raphael E Steiner, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5291.
https://doi.org/10.1182/blood-2019-125980
Published: 2019
Journal Articles

Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Clinical Studies, and MD Anderson

Free
Ethan Burns, MD, Kartik Anand, MD, Jason R. Westin, MD, Sai Ravi Kiran Pingali, MD, Joe Ensor, PhD, Dahlia Sano, MD, Loretta J. Nastoupil, MD MSc, Hun Ju Lee, Yago Nieto, MD PhD, Issa F. Khouri, MD, Felipe Samaniego, MD, Simrit Parmar, MBBS, Michael Wang, MD, Misha Hawkins, Sherry Adkins, ANP, Luis E. Fayad, MD, Raphael E Steiner, MD, Ranjit Nair, MBBS,MD, Sairah Ahmed, MD, Nathan H. Fowler, MD, Sattva S Neelapu, MD, Swaminathan P. Iyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1931.
https://doi.org/10.1182/blood-2019-131077
Published: 2019
Journal Articles

Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma

Free
Dahlia Sano, MBBCH, Loretta J. Nastoupil, MD, Nathan H. Fowler, MD, Luis Fayad, MD, F. B. Hagemeister, MD, Hun Ju Lee, MD, Felipe Samaniego, MD, Michael Wang, MD, Maria Alma Rodriguez, MD, Swaminathan P Iyer, MD, Simrit Parmar, MBBS, Raphael Steiner, MD, Ranjit Nair, MBBS,MD, Sherry Adkins, ANP, Sara Arafat, MD, Ahalya Rao, MD, Liliana Vallejo, Misha Hawkins, Yiming Chen, Jason R. Westin, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 96.
https://doi.org/10.1182/blood-2018-99-120013
Published: 2018
Journal Articles

The Utility of End of Treatment PET-CT in Patients with Diffuse Large B-Cell Lymphoma and Documented Complete Remission By Interim PET

Free
Dahlia Sano, MBBCH, Susan Szpunar, Kleanthe Kolizeras, Ayad Al-Katib, MD FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4702.
https://doi.org/10.1182/blood.V130.Suppl_1.4702.4702
Published: 2017